Impact of molecular subtype and race on HR+, HER2- breast cancer survival.
Reid S, Haddad D, Tezak A, Weidner A, Wang X, Mautz B, Moore J, Cadiz S, Zhu Y, Zheng W, Mayer IA, Shu XO, Pal T.
Reid S, et al. Among authors: weidner a.
Breast Cancer Res Treat. 2021 Oct;189(3):845-852. doi: 10.1007/s10549-021-06342-0. Epub 2021 Jul 31.
Breast Cancer Res Treat. 2021.
PMID: 34331630
Free PMC article.